Protein farnesylation: implications for normal physiology, malignant transformation, and cancer therapy
1Drug Discovery Program, H. Lee Moffitt Cancer Center & Research Institute, Department of Interdisciplinary Oncology, University of South Florida College of Medicine, Tampa, Florida 33612, USA. sebti@moffitt.usf.edu
Abstract:
Protein farnesylation is a lipid posttranslational modification required for the cancer-causing activity of proteins such as the GTPase Ras. Although farnesyltransferase inhibitors (FTIs) are in clinical trials, their mechanism of action and the role of protein farnesylation in normal physiology are ill understood. In this issue of Cancer Cell, two articles shed light on these important issues. Protein farnesylation was found to be essential for early embryogenesis, dispensable for adult homeostasis, and critical for progression but not initiation of tumorigenesis. Furthermore, Rab geranylgeranyltransferase was identified as a target for some FTIs. This minireview discusses the implications of these findings on normal physiology, malignant transformation, and cancer therapy.
Insights
Protein farnesylation is vital for early development and cancer progression, but not adult health. Farnesyltransferase inhibitors (FTIs) show promise, targeting Rab geranylgeranyltransferase in cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Protein farnesylation is a critical lipid modification for oncogenic proteins like Ras.
- The precise role of protein farnesylation in normal physiology and cancer remains unclear.
- Farnesyltransferase inhibitors (FTIs) are under clinical investigation for cancer treatment.
Purpose of the Study:
- To elucidate the role of protein farnesylation in normal physiological processes.
- To investigate the involvement of protein farnesylation in tumorigenesis.
- To identify novel targets for farnesyltransferase inhibitors in cancer therapy.
Main Methods:
- Analysis of protein farnesylation's essentiality in embryogenesis and adult homeostasis.
- Assessment of protein farnesylation's role in tumor initiation versus progression.
- Identification of molecular targets for farnesyltransferase inhibitors.
Main Results:
- Protein farnesylation is essential for early embryogenesis but dispensable for adult homeostasis.
- Farnesylation is critical for cancer progression, not initiation.
- Rab geranylgeranyltransferase is identified as a target for certain FTIs.
Conclusions:
- Protein farnesylation plays distinct roles in development, homeostasis, and cancer.
- FTIs targeting Rab geranylgeranyltransferase offer potential therapeutic strategies.
- Understanding farnesylation mechanisms is key for advancing cancer therapy.
More Related Videos
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...


